Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy

2017 ◽  
Vol 166 (2) ◽  
pp. 473-480 ◽  
Author(s):  
Young-Joon Kang ◽  
Wonshik Han ◽  
Soojin Park ◽  
Ji Young You ◽  
Ha Woo Yi ◽  
...  
2006 ◽  
Vol 191 (2) ◽  
pp. 225-229 ◽  
Author(s):  
Takayuki Kinoshita ◽  
Miyuki Takasugi ◽  
Eriko Iwamoto ◽  
Sadako Akashi-Tanaka ◽  
Takashi Fukutomi ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-5 ◽  
Author(s):  
Hazem Assi ◽  
Eman Sbaity ◽  
Mahmoud Abdelsalam ◽  
Ali Shamseddine

Sentinel lymph node biopsy (SLNB) emerged in the 1990s as a new technique in the surgical management of the axilla for patients with early breast cancer, resulting in lower complication rates and better quality of life than axillary lymph node dissection (ALND). Today SLNB is firmly established in the armamentarium of clinicians treating breast cancer, but several questions remain. The goal of this paper is to review recent work addressing 4 questions that have been the subject of debate in the use of SLNB in the past few years: (a) What is the implication of finding micrometastases in the sentinel nodes? (b) Is ALND necessary in all patients who have a positive SLNB? (c) How accurate is SLNB after neoadjuvant therapy? (d) Can SLNB be used to stage the axilla in locally recurrent breast cancer following breast surgery with or without prior axillary surgery?


Cancer ◽  
2011 ◽  
Vol 117 (20) ◽  
pp. 4606-4616 ◽  
Author(s):  
Vaclav Pecha ◽  
Dusan Kolarik ◽  
Renata Kozevnikova ◽  
Karolina Hovorkova ◽  
Petruse Hrabetova ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document